Filing Flows › Cardio Diagnostics Holdings (CDIO) › Q1 2025
Cardio Diagnostics Holdings (CDIO) Q1 2025 earnings results (first quarter 2025)
10-Q filed May 15, 2025
Cardio Diagnostics Holdings (CDIO) reported revenue of $1K for the first quarter 2025 (Q1 2025), -94% from a year earlier and -79% from the quarter before.
Cardio Diagnostics Holdings, Q1 2025: revenue $1K (-94% year over year), net loss $1.6M, operating cash flow −$1.4M. The chart follows the revenue to costs, profit and cash.
| Q1 2025 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $1K | -79% | -94% |
| Operating profit | −$1.6M | — | — |
| Net earnings | −$1.6M | — | — |
| Operating cash flow | −$1.4M | — | — |
What changed
Revenue was $1K in Q1 2025, down 94% year over year and down 79% from the previous quarter.
Operating costs exceeded revenue by $1.6M, an operating margin of -173463.8%. Total costs fell 61% while revenue fell 94%. The fastest-growing cost line was Sales & marketing (+22%). The quarter ended with a net loss of $1.6M, wider than the previous quarter's $1.5M loss.
Operating cash flow was −$1.4M. Non-cash charges added back $45K of depreciation and amortization and $31K of share-based compensation. Working capital and other items added $159K. Capital expenditures of $6K exceeded it, leaving free cash flow of −$1.4M.
Questions
What was Cardio Diagnostics Holdings' revenue in the first quarter 2025?
Cardio Diagnostics Holdings (CDIO) reported revenue of $1K for the first quarter 2025 (Q1 2025), -94% from a year earlier and -79% from the quarter before.